Senate investigation uncovers 'bad actors' behind off-patent drug price gouging | Pharmaceutical | The Pharmaletter | The Pharmaletter

Patents, Intellectual Property News

The US Senate's Special Committee on Aging has published a damning report on pharma companies' manipulation of loopholes in the system so they can ...